The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
50 reports and counting
Net Health Names Patrick Rooney Interim Chief Executive Officer
Net Health appointed COO Patrick Rooney interim CEO as Ron Books transitions from CEO to executive chairman, with the Board searching for a permanent CEO.
Solstice Oncology Raises $225M Series A for Neoadjuvant Immuno-Oncology
Solstice Oncology launched with a $225 million Series A led by RA Capital Management to advance porustobart, a neoadjuvant immuno-oncology therapy.
Typewriter Therapeutics Raises $56M Series A for In Vivo CAR T Medicines
Typewriter Therapeutics emerged from stealth with a $56 million Series A led by AN Venture Partners and RA Capital Management to develop in vivo CAR T medicines.
AusperBio Raises $120M Series C for Hepatitis B Oligonucleotide Therapies
AusperBio closed a $120 million Series C led by a strategic investor, with new investor RA Capital participating, to advance its hepatitis B candidate AHB-137.
Amplifica Raises $26M Series B for Injectable Hair Growth Therapies
Amplifica raised an oversubscribed $26 million Series B led by Tasso Partners to advance clinical development of its injectable hair-growth pipeline.
Beyang Raises Nearly $30M Series A for AI-Driven Drug Discovery
Beyang Therapeutics raised nearly $30 million in an oversubscribed Series A co-led by Legend Capital and Shanghai Healthcare Capital to advance its AI-driven drug discovery platform and pipeline.
Ratio Therapeutics Raises $70M Series C for Targeted Radiotherapeutics
Ratio Therapeutics closed a $70 million Series C financing with existing and new investors and expects to use the funding to advance its ongoing ATLAS study and move its next-generation RLT candidate into the clinic.
Telum Therapeutics Raises €18M Series A for Protein-Based Antimicrobials
Telum Therapeutics raised an €18 million Series A led by AMR Action Fund to advance its lead antimicrobial program through Phase 1 clinical development.
Dualitas Therapeutics Appoints Karim Dabbagh Chief Executive Officer
Dualitas Therapeutics appointed Karim Dabbagh, formerly President and CEO of Silver Creek Pharmaceuticals, as Chief Executive Officer, with former interim CEO Rich Murray remaining on the Board of Directors.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.